Your browser doesn't support javascript.
loading
A rare case of B-lymphoid blast phase of chronic myeloid leukemia: Diagnostic challenges.
Naiyer, Nada; Zaslav, Ann-Leslie; Ahmed, Tahmeena; Spitzer, Silvia; Ma, Yupo; Ponce, Roxanna; Lee, Htien; Lin, Hong.
Afiliação
  • Naiyer N; Department of Pathology, Stony Brook University School of Medicine, 101 Nicolls Road, Stony Brook, New York 11794-7300, United States.
  • Zaslav AL; Department of Pathology, Stony Brook University School of Medicine, 101 Nicolls Road, Stony Brook, New York 11794-7300, United States.
  • Ahmed T; Department of Pathology, Stony Brook University School of Medicine, 101 Nicolls Road, Stony Brook, New York 11794-7300, United States.
  • Spitzer S; Department of Pathology, Stony Brook University School of Medicine, 101 Nicolls Road, Stony Brook, New York 11794-7300, United States.
  • Ma Y; Department of Pathology, Stony Brook University School of Medicine, 101 Nicolls Road, Stony Brook, New York 11794-7300, United States.
  • Ponce R; Department of Pathology, Stony Brook University School of Medicine, 101 Nicolls Road, Stony Brook, New York 11794-7300, United States.
  • Lee H; Department of Pathology, Stony Brook University School of Medicine, 101 Nicolls Road, Stony Brook, New York 11794-7300, United States.
  • Lin H; Department of Pathology, Stony Brook University School of Medicine, 101 Nicolls Road, Stony Brook, New York 11794-7300, United States.
Leuk Res Rep ; 17: 100327, 2022.
Article em En | MEDLINE | ID: mdl-35634195
ABSTRACT
Chronic myeloid leukemia(CML) is characterized by Philadelphia(Ph) chromosome. About 5% of cases are diagnosed in blast phase. We report a case of a 53-year-old female with no significant medical history, in B-lymphoblast crisis. Flow cytometry demonstrated B-lymphoblasts with no myeloid aberrancies, together with immature neutrophils in blood, and B-lymphoblasts in bone marrow. Cytogenetic studies identified Ph+ with complex abnormalities. Molecular analysis showed positive both for p210 and p190 transcripts in blood. ABL1 mutation analysis by Next Generation Sequencing(NGS) detected Thr315Ile mutation, which confers resistance to many tyrosine kinase inhibitors(TKIs). Eight months later she received allogeneic transplant and is doing well.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Leuk Res Rep Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Leuk Res Rep Ano de publicação: 2022 Tipo de documento: Article